# Othram

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/othram

- Industry: Biotechnology
- Headquarters: The Woodlands, US
- Website: www.othram.com
- Total disclosed funding: $22M
- Latest round: Series B (Sep 16, 2021)
- Investors on record: 2

## About

Othram, Inc. is a US-based company specializing in advanced forensic DNA analysis, providing vital services to law enforcement and governments for identifying human remains and resolving missing persons cases.Founded in 2018 by David Mittelman, Othram, Inc. is headquartered in The Woodlands, Texas, US. The company has successfully completed three funding deals, with the latest being a Series B round in September 2021, raising USD 18.00 mn led by Gigafund. David Mittelman has a history of founding and leading companies in the technology sector.Othram specializes in advanced forensic DNA analysis, offering crucial services to law enforcement and government agencies for identifying human remains and resolving missing persons cases. Their core offerings include in-house processing of forensic evidence, which encompasses DNA extraction, enrichment, sequencing, and genealogical analysis conducted within an accredited laboratory. Utilizing proprietary technologies such as KinSNP® analysis and the DNASolves® database, Othram addresses traditional forensic DNA challenges, enabling the identification of previously unsolvable cases. Their clientele includes local, state, and federal law enforcement agencies across the United States, as well as international partners, impacting markets in North America, Australia, and beyond.Othram generates revenue through its forensic DNA testing services, primarily operating on a B2B model by collaborating with law enforcement agencies and medical examiners. Clients contract Othram for its specialized forensic analysis expertise, often through project-based agreements tailored to specific casework requirements. The firm's revenue consists of service fees for various stages of DNA analysis, including initial assessments, full DNA testing, and genealogical research, with pricing contingent on the complexity and scope of each case. Key services like KinSNP® analysis and the DNASolves® database are integral to their offerings, reflecting the company's commitment to reliable forensic solutions.In September 2021, Othram, Inc. raised USD 18.00 mn in Series B funding led by Gigafund. The company plans to utilize this funding to enhance its technology and accelerate the development of its genetic testing platform. Furthermore, Othram aims to expand operations throughout North America, targeting new markets and regions to improve the accessibility of their forensic DNA services.

## Funding rounds

- Series B, Sep 16, 2021, $18M — Gigafund
- Series A, Mar 12, 2019, $4M — Nimble Ventures

## Investors

- Nimble Ventures (https://capitalatlas.ai/funds/nimble-ventures) — Series A
- Gigafund (https://capitalatlas.ai/funds/gigafund) — Series B